Related Experiment Video

Updated: Aug 9, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis

K Boisvert-Adamo1, A E Aplin

  • 1Center for Cell Biology and Cancer Research, Albany Medical College, Albany, NY 12208, USA.

Oncogene
|March 21, 2006
PubMed

Insights

Melanoma cells resist anoikis, a form of apoptosis, through B-RAF or PI-3 kinase pathways. Fibronectin adhesion protects cells via PI-3 kinase, while B-RAF inhibition increases anoikis susceptibility.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Cancer cells often resist anoikis, a programmed cell death triggered by detachment from the extracellular matrix.
  • Melanoma exhibits significant resistance to apoptosis, with B-RAF mutations and PI-3 kinase/AKT pathway alterations common in advanced stages.
  • B-RAF mutations drive MEK-ERK signaling, promoting melanoma cell transformation and invasion into collagen and fibronectin-rich environments.

Purpose of the Study:

  • To investigate the signaling pathways conferring anoikis resistance in melanoma cells.
  • To determine the role of B-RAF and PI-3 kinase signaling in melanoma cell survival.
  • To explore the impact of extracellular matrix components like fibronectin and collagen on anoikis resistance.

Main Methods:

  • Utilized small interfering RNA (siRNA) to knockdown B-RAF expression in melanoma cells.
  • Employed pharmacological inhibition of MEK to block MEK-ERK signaling.
  • Assessed anoikis susceptibility following B-RAF/MEK inhibition and cell adhesion to fibronectin or collagen.
  • Investigated the involvement of the PI-3 kinase/AKT pathway in anoikis resistance.

Main Results:

  • Knockdown of B-RAF or inhibition of MEK sensitized melanoma cells to anoikis.
  • Adhesion to fibronectin, but not collagen, protected melanoma cells from anoikis.
  • This fibronectin-mediated protection was dependent on PI-3 kinase activation.
  • Melanoma cells require either B-RAF or PI-3 kinase pathway activation to resist anoikis.

Conclusions:

  • Melanoma cells employ distinct signaling pathways, including B-RAF and PI-3 kinase, to evade anoikis.
  • Fibronectin interaction with melanoma cells promotes survival through PI-3 kinase signaling.
  • Targeting B-RAF or PI-3 kinase pathways could represent therapeutic strategies for overcoming anoikis resistance in melanoma.

More Related Videos

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression11:02

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...